Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats

American Journal of Physiology - Renal Physiology

Volumn 279, Issue 1 48-1, 2000, Pages

  Hsieh, Tusty Jiuan ^a   Lin, Shiu Ru ^a   Lee, Yau Jiunn ^b   Shin, Shyi Jang ^a   Lai, Yung Hsiung ^a   Hsu, Chin Hsun ^a   Tsai, Juei Hsiung ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Endothelin A receptor; Endothelin B receptor; Endothelin converting enzyme 1

Indexed keywords

DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN CONVERTING ENZYME; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FLUID BALANCE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY FUNCTION; KIDNEY MEDULLA; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RECEPTOR BINDING; SODIUM BALANCE;

EID: 0033860565     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2000.279.1.f112     Document Type: Article

References (41)

1. Ando K, Hirata Y, Takei Y, Kawakami M, and Marumo F. Endothelin-1-like immunoreactivity in human urine. Nephron 57: 36-39, 1991.
2. Benigni A, Perico N, Gaspari F, Zoja C, Bellizzi L, Gabanelli M, and Remuzzi G. Increased renal endothelin production in rats with reduced renal mass. Am J Physiol Renal Fluid Electrolyte Physiol 260: F331-F339, 1991.
3. Berbinschi A and Ketelslegers JM. Endothelin in urine. Lancet ii: 46, 1989.
4. Brooks DP, DePalma PD, Pullen M, and Nambi P. Characterization of canine renal endothelin receptor subtypes and their function. J Pharmacol Exp Ther 268: 1091-1097, 1994.
5. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
6. Ciinzia P, Brunori M, Misciglia N, Selli C, Ianni L, Yanagisawa M, Mannelli M, and Serio M. Presence and distribution of endothelin-1 gene expression in human kidney. Am J Physiol Renal Fluid Electrolyte Physiol 267: F679-F687, 1994.
7. Deng LY, Day R, and Schiffrin EL. Localization of sites of enhanced expression of endothelin-1 in the kidney of DOCA-salt hypertensive rats. J Am Soc Nephrol 7: 1158-1164, 1996.
8. Emoto N and Yanagisawa M. Endothelin-converting en-zyme-2 is a membrane-bound phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270: 15262-15268, 1995.
9. Garcia NH and Garvin JL. Endothelin biphasic effect on fluid absorption in the proximal straight tubule and its inhibitory cascade. J Clin Invest 93: 2572-2577, 1994.
10. Gomez-Garre D, Ruiz-Ortega M, Ortego M, Largo R, Lopez-Armada MJ, Plaza JJ, Gonzalez E, and Egido J. Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension 27: 885-892, 1996.
11. Hocher B, Rohmeiss P, Zart R, Diekmann F, Vogt V, Metz D, Fakhury M, Gretz N, Bauer C, Koppenhagen K, Neumayer HH, and Distler A. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats. Cardiovasc Res 31: 499-510, 1996.
12. Hoffman A, Grossman E, Goldstein DS, Gill JR Jr, and Keiser HR. Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity. Kidney Int 45: 556-560, 1994.
13. Hosoda K, Nakao K, Tamura N, Arai H, Ogawa Y, Suga S, Nakanishi S, and Imura H. Organization, structure, chromosomal assignment, and expression of the gene encoding the human endothelin-A receptor. J Biol Chem 267: 18787-18804, 1992.
14. Hwang Y-S, Hsieh T-J, Lee Y-J, and Tsai J-H. Circadian rhythm of urinary endothelin-1 excretion in mild hypertensive patients. Am J Hypertens 11: 1344-1352, 1998.
15. King AJ, Brenner BM, and Anderson S. Endothelin: a potent renal and systemic vasoconstrictor peptide. Am J Physiol Renal Fluid Electrolyte Physiol 256: F1051-F1058, 1989.
16. Kitamura K, Tanaka T, Kato J, Eto T, and Tanaka K. Regional distribution of immunoreactive endothelin in porcine tissue: abundance in inner medulla of kidney. Biochem Biophys Res Commun 161: 348-352, 1989.
17. Kohan DE. Endothelins in the normal and diseased kidney. Am J Kidney Dis 29: 2-26, 1997.
18. Kohan DE. Endothelins in the kidney: physiology and pathophysiology. Am J Kidney Dis 22: 493-510, 1993.
19. Kohan DE. Endothelins: renal tubule synthesis and actions. Clin Exp Pharmacol Physiol 23: 337-344, 1996.
20. Larieviere R, Thibault G, and Schiffrin EL. Increased endothelin-1 content in blood vessels of deoxycorticosterone acetate-salt hypertensive but not in spontaneously hypertensive rats. Hypertension 21: 294-300, 1993.
21. Larieviere R, Day R, and Schiffrin EL. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension 21: 916-920, 1993.
22. Lee Y-J, Shin S-J, and Tsai J-H. Increased urinary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria. Diabetes Care 17: 263-266, 1994.
23. Lee Y-J, Shin S-J, Tan M-S, Hsieh T-J, and Tsai J-H. Increased renal atrial natriuretic peptide synthesis in rats with deoxycorticosterone acetate-salt treatment. Am J Physiol Renal Fluid Electrolyte Physiol 271: F779-F789, 1996.
24. Luscher TF, Seo B, and Buhler FR. Potential role of endothelin in hypertension: controversy on endothelin in hypertension. Hypertension 21: 752-757, 1993.
25. Masaki T, Kimura S, Yanagisawa M, and Goto K. Molecular and cellular mechanism of endothelin regulation. Implications for vascular function. Circulation 84: 1457-1468, 1991.
26. Matsumura Y, Hashimoto N, Fugita K, and Morimoto S. Ameliorating effect of endothelin ETA receptor antagonist on renal function of DOCA-salt hypertensive rats. Eur J Pharmacol 319: 65-69, 1997.
27. Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, Ohkita M, Opgenorth TJ, and Takaoka M. Different distribution of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats. Hypertension 33: 759-765, 1999.
28. Minamino T, Kurihara H, Takahashi M, Shimada K, Maemura K, Oda H, Ishikawa T, Uchiyama T, Tanzawa K, and Yazaki Y. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Circulation 95: 221-230, 1997.
29. Mortensen LH and Fink GD. Salt-dependency of endothelin-induced, chronic hypertension in conscious rats. Hypertension 19: 549-554, 1992.
30. Mortensen LH, Pawlaski CM, Kanagy NL, and Fink GD. Chronic hypertension produced by infusion of ET-1 in rats. Hypertension 15: 729-733, 1990.
31. Nambi P, Pullem M, Wu H-L, Aiyar N, Ohlstein E, and Edwards R. Identification of endothelin receptors in human renal cortex and medulla using subtype-selective ligands. Endocrinology 131: 1081-1086, 1992.
32. Nambim P, Wu H-L, Pullem M, Aiyar N, and Elliott J. Identification of endothelin receptor types in rat kidney cortex using subtype-selective ligands. Mol Pharmacol 42: 336-339, 1992.
33. Nunez DJR, Brown MJ, Davemport AP, Neylon CB, Schofield JP, and Wyse R. Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest 85: 1537-1541, 1990.
34. B endothelin receptor. Biochem Biophys Res Commun 178: 656-663, 1991.
35. Serneri N, Gastone G, Modesti PA, Cecioni I, Biagini D, Migliorini A, Costoli A, Colella A, Naldoni A, and Paoletti P. Plasma endothelin and renal endothelin are two distinct systems involved in volume homeostasis. Am J Physiol Heart Circ Physiol 268: H1829-H1837, 1995.
36. 15]-endothelin-1(11-21). FEBS Lett 311: 12-16, 1992.
37. Wilkes BM, Susin M, Mento PF, Macica CM, Girardi EP, Boss E, and Nord EP. Location of endothelin-like immunoreactivity in rat kidneys. Am J Physiol Renal Fluid Electrolyte Physiol 260: F913-F920, 1991.
38. Xu D, Emoto N, Giaid A, Glaughter C, Raw S, deWit D, and Yanagisawa M. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78: 473-485, 1994.
39. Yanagisawa M, Kurihara H, Kimura S, Tombe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto Y, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
40. B receptor agonist, IRL 1620. Eur J Pharmacol 264: 399-405, 1994.
41. +ATPase in intact renal tubular epithelial cells. Am J Physiol Cell Physiol 257: C1101-C1107, 1989.